Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 17/20 | 0.81 |
| ▸ | CCR3 | P51677 | 1/20 | 0.49 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7925934 | 0.94 | TACR1 (0.72) | TACR1CCR3 | |
| SCHEMBL7989837 | 0.90 | TACR1 (1.00) | TACR1CCR3MCHR1 | |
| SCHEMBL7989833 | 0.84 | TACR1 (0.71) | TACR1 | |
| SCHEMBL7925929 | 0.83 | TACR1 (0.88) | TACR1CCR3 | |
| SCHEMBL7934611 | 0.82 | TACR1 (0.56) | TACR1CCR3MCHR1 | |
| SCHEMBL7934599 | 0.82 | TACR1 (1.00) | TACR1CCR3 | |
| SCHEMBL7926223 | 0.78 | TACR1 (1.00) | TACR1 | |
| SCHEMBL7975474 | 0.78 | TACR1 (0.81) | TACR1CCR3 | |
| SCHEMBL9054531 | 0.77 | TACR1 (0.98) | TACR1 | |
| SCHEMBL7938485 | 0.75 | TACR1 (0.86) | TACR1CCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6191135-B1 | Neurokinin antagonists | BOEHRINGER INGELHEIM KG (DE) | 2001-02-20 | — | — | US | claimed |
| US-6191135-B1 | Neurokinin antagonists | BOEHRINGER INGELHEIM KG (DE) | 2001-02-20 | — | — | US | disclosed |
| US-5985881-A | TREATMENT AND PREVENTION OF RESPIRATORY DISORDERS, INFLAMMATORY EYE DISEASES, INFLAMMATORY SKIN DISEASES, INTESTINAL DISORDERS, OTHER INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM KG (DE) | 1999-11-16 | — | — | US | disclosed |